Literature DB >> 26986489

Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data.

Huizhen Sun1, Li Yan, Ruiqin Tu, Yuqin Zhang, Li Ma, Wenbin Tang, Long Li, Wei Chen, Cheng Zhan, Rongyu Zang.   

Abstract

BACKGROUND: This study was to explore the expression profile of endometrial carcinoma (EC) and identify the potential molecular mechanism and therapeutic targets.
METHODS: Differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) were identified in EC using mRNA and miRNA sequencing data released by the Cancer Genome Atlas database; then, gene function and pathway of DEGs were analyzed based on the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway databases; finally, the transcription factors (TFs) latently regulating the DEGs and DEMs were predicted and a TF-miRNA-Gene network was then established to summarize the regulatory links between TFs, DEMs and DEGs.
RESULTS: One thousand five hundred and forty two upregulated and 1,885 downregulated DEGs, 34 upregulated and 12 downregulated DEMs were identified. The principal DEGs-enriched functions were cell differentiation, cell migration, and cell surface receptor signaling pathway. The DEGs-enriched cell signaling pathways including the MAPK, Wnt signaling pathway, and the p53 signaling pathway. As shown in the TF-miRNA-Gene network, TFs such as CPBP and GKLF, miRNAs such as miR-141-3p and miR-130b-3p, regulated most of DEGs and DEMs.
CONCLUSION: These results may contribute to the study of the molecular mechanism and therapeutic targets in EC, and facilitate the discovery of new biomarkers for screening, diagnosis and monitoring.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26986489     DOI: 10.1159/000445073

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.

Authors:  Mikaël Agopiantz; Patricia Forgez; Jean-Matthieu Casse; Stéphanie Lacomme; Claire Charra-Brunaud; Isabelle Clerc-Urmès; Olivier Morel; Céline Bonnet; Jean-Louis Guéant; Jean-Michel Vignaud; Anne Gompel; Guillaume Gauchotte
Journal:  Virchows Arch       Date:  2017-08-24       Impact factor: 4.064

2.  PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient.

Authors:  Krishna R Kalari; Jason P Sinnwell; Kevin J Thompson; Xiaojia Tang; Erin E Carlson; Jia Yu; Peter T Vedell; James N Ingle; Richard M Weinshilboum; Judy C Boughey; Liewei Wang; Matthew P Goetz; Vera Suman
Journal:  JCO Clin Cancer Inform       Date:  2018-12

3.  Necroptosis-Related miRNA Biomarkers for Predicting Overall Survival Outcomes for Endometrial Cancer.

Authors:  Hualin Song; Tianjie Li; Jindong Sheng; Dan Li; Xiangyu Liu; Huiting Xiao; Hu Yu; Wenxin Liu; Ke Wang; Ying Chen
Journal:  Front Genet       Date:  2022-05-27       Impact factor: 4.772

4.  Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.

Authors:  Judicaël Hotton; Mikaël Agopiantz; Agnès Leroux; Claire Charra-Brunaud; Béatrice Marie; Hélène Busby-Venner; Olivier Morel; Jean-Louis Guéant; Jean-Michel Vignaud; Shyue-Fang Battaglia-Hsu; Guillaume Gauchotte
Journal:  Virchows Arch       Date:  2017-12-14       Impact factor: 4.064

5.  Evaluation Analysis of miRNAs Overexpression in Liquid-Based Cytology Endometrial Samples.

Authors:  Christine Kottaridi; Aris Spathis; Niki Margari; Nikolaos Koureas; Emmanouil Terzakis; Charalampos Chrelias; Asimakis Pappas; Evripidis Bilirakis; Abraham Pouliakis; Ioannis J Panayiotides; Petros Karakitsos
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

6.  RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.

Authors:  Zonggao Shi; Chunyan Li; Laura Tarwater; Jun Li; Yang Li; William Kaliney; Darshan S Chandrashekar; M Sharon Stack
Journal:  J Oncol       Date:  2018-02-14       Impact factor: 4.375

7.  Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network.

Authors:  Ming-Jun Zheng; Rui Gou; Wen-Chao Zhang; Xin Nie; Jing Wang; Ling-Ling Gao; Juan-Juan Liu; Xiao Li; Bei Lin
Journal:  PeerJ       Date:  2018-12-10       Impact factor: 2.984

8.  Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.

Authors:  Qian Wang; Kai Xu; Yu Tong; Xianning Dai; Teng Xu; Danna He; Jianchao Ying
Journal:  J Cell Mol Med       Date:  2020-03-09       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.